|Philip G Vanek PhD said cell therapy is moving closer to a mature market|
GE Healthcare general manager of cell therapy technologies Philip G Vanek PhD told attendees at Cell Therapy Bioprocessing & Commercialization that industries evolve down similar tracks: discovery, development, manufacturing.
“The biology of CTs has happened, process development and optimization is currently happening, a mature CT market is coming,” he said. However, he stressed the need for bespoke tools, "to design equipment that will be needed in the future”.
He pointed to five key areas that need development:
- Connect unit operations – increase the use of closed systems to increase repeatability
- Drive towards automation – decrease human interaction and involvement
- Contain costs per unit
- Manage talent – with scale comes need to more trained staff
- Risk management
Join the conversation on Twitter by following #IBC_CTB15
Share this article with your social network, just click below to share now!